INVO Fertility (IVF) Cash from Operations Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.57% |
| Jun 30, 2025 | -8.34% |
| Mar 31, 2025 | -32.64% |
| Dec 31, 2024 | 4.35% |
| Sep 30, 2024 | -2.93% |
| Jun 30, 2024 | -30.67% |
| Mar 31, 2024 | -15.82% |
| Dec 31, 2023 | -20.08% |
| Sep 30, 2023 | -60.49% |
| Jun 30, 2023 | -50.62% |
| Mar 31, 2023 | -98.41% |
| Dec 31, 2022 | -119.97% |
| Sep 30, 2022 | -126.84% |
| Jun 30, 2022 | -144.18% |
| Mar 31, 2022 | -79.10% |
| Dec 31, 2021 | -72.65% |
| Sep 30, 2021 | -95.05% |
| Jun 30, 2021 | -63.74% |
| Mar 31, 2021 | -90.77% |
| Dec 31, 2020 | -77.76% |
| Sep 30, 2020 | -106.47% |
| Jun 30, 2020 | -198.61% |
| Mar 31, 2020 | -114.19% |
| Dec 31, 2019 | -151.60% |
| Sep 30, 2019 | -199.49% |
| Jun 30, 2019 | -207.78% |
| Mar 31, 2019 | 210.52% |
| Dec 31, 2018 | -81.66% |
| Sep 30, 2018 | -64.34% |
| Jun 30, 2018 | -73.71% |
| Mar 31, 2018 | -10.91% |
| Dec 31, 2017 | 5.22% |
| Sep 30, 2017 | -7.90% |
| Jun 30, 2017 | -108.83% |
| Mar 31, 2017 | -197.99% |
| Dec 31, 2016 | -32.79% |
| Sep 30, 2016 | 0.45% |